Article Text

other Versions


Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population-based study

Statistics from

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview
  • Competing interest: EB-S is employed by AstraZeneca, R&D, Sweden. NJT has received speaker fees, research fees, and consulting fees from AstraZeneca.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.